ARKG ETF Analysis & Comprehensive Review (April 2026)
What is the ARKG (ARKG)?
The ARKG, traded under the ticker ARKG, is an exchange-traded fund (ETF) operating within the Thematic - Genomics category. As part of the broader Equity asset class, this fund is managed by Otherand provides investors with targeted exposure to its underlying benchmark.
ARKG Rating and Quantitative Profile
As of April 2026, the Blank Capital quantitative model assigns ARKG a Hold rating, driven by a composite score of 58.0 out of 100. This proprietary ranking evaluates the ETF across five core dimensions: cost efficiency, historical performance, momentum, liquidity, and tracking error.
Breaking down the factor DNA, ARKG scores 50/100 for Cost Efficiency, indicating its fee structure relative to category peers. Its Performance Score sits at 50/100, while Momentum is measured at 50/100. Furthermore, the fund earns a Liquidity Score of 100/100 and a Tracking Score of 50/100, which evaluates how closely the fund replicates its intended benchmark without structural deviation.
Is ARKG Expensive? (Expense Ratio Analysis)
Cost is a critical determinant of long-term ETF returns. The ARKG ETF carries an expense ratio of N/A, meaning investors pay approximately $0 annually for every $10,000 invested. This fee is relatively standard for the category, representing a fair price for the exposure provided.
ARKG vs Competitors and Alternatives
When allocating capital, it is essential to compare ARKG against its closest category competitors. Top-rated alternatives in the Thematic - Genomics space include:
Conducting a head-to-head comparison helps identify which fund offers the optimal balance of fees, liquidity, and factor exposure for your portfolio strategy.
Final Verdict: Should You Invest in ARKG?
With a Hold rating and a 58.0/100 composite score, ARKG (ARKG) presents a reasonable option within the Thematic - Genomics universe. Investors seeking exposure to the Equity market should evaluate whether the fund's fee structure and historical tracking metrics align with their broader portfolio objectives and risk tolerance.